Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/3977
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Amiten_US
dc.date.accessioned2022-03-17T01:00:00Z-
dc.date.accessioned2022-03-17T15:31:13Z-
dc.date.available2022-03-17T01:00:00Z-
dc.date.available2022-03-17T15:31:13Z-
dc.date.issued2019-
dc.identifier.citationJoshi, V., Mishra, R., Upadhyay, A., Amanullah, A., Poluri, K. M., Singh, S., . . . Mishra, A. (2019). Polyphenolic flavonoid (myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation. Journal of Cellular Physiology, 234(11), 20900-20914. doi:10.1002/jcp.28695en_US
dc.identifier.issn0021-9541-
dc.identifier.otherEID(2-s2.0-85069643348)-
dc.identifier.urihttps://doi.org/10.1002/jcp.28695-
dc.identifier.urihttps://dspace.iiti.ac.in/handle/123456789/3977-
dc.description.abstractMajor neurodegenerative disorders are characterized by the formation of misfolded proteins aggregates inside or outside the neuronal cells. Previous studies suggest that aberrant proteins aggregates play a critical role in protein homeostasis imbalance and failure of protein quality control (PQC) mechanism, leading to disease conditions. However, we still do not understand the precise mechanisms of PQC failure and cellular dysfunctions associated with neurodegenerative diseases caused by the accumulation of protein aggregates. Here, we show that Myricetin, a flavonoid, can eliminate various abnormal proteins from the cellular environment via modulating endogenous levels of Hsp70 chaperone and quality control (QC)-E3 ubiquitin ligase E6-AP. We have observed that Myricetin treatment suppresses the aggregation of different aberrant proteins. Myricetin also enhances the elimination of various toxic neurodegenerative diseases associated proteins from the cells, which could be reversed by the addition of putative proteasome inhibitor (MG132). Remarkably, Myricetin can also stabilize E6-AP and reduce the misfolded proteins inclusions, which further alleviates cytotoxicity. Taken together these findings suggested that new mechanistic and therapeutic insights based on small molecules mediated regulation of disturbed protein quality control mechanism, which may result in the maintenance of the state of proteostasis. © 2019 Wiley Periodicals, Inc.en_US
dc.language.isoenen_US
dc.publisherWiley-Liss Inc.en_US
dc.sourceJournal of Cellular Physiologyen_US
dc.subjectalpha synucleinen_US
dc.subjectbenzyloxycarbonylleucylleucylleucinalen_US
dc.subjectchaperoneen_US
dc.subjectgreen fluorescent proteinen_US
dc.subjectheat shock protein 70en_US
dc.subjectmyricetinen_US
dc.subjectubiquitin protein ligase E3en_US
dc.subjectalpha synucleinen_US
dc.subjectflavonoiden_US
dc.subjectluciferaseen_US
dc.subjectmutant proteinen_US
dc.subjectmyricetinen_US
dc.subjectpeptideen_US
dc.subjectpolyglutamineen_US
dc.subjectpolyphenolen_US
dc.subjectproteasomeen_US
dc.subjectprotein aggregateen_US
dc.subjectsuperoxide dismutaseen_US
dc.subjectUBE3A protein, humanen_US
dc.subjectubiquitin protein ligaseen_US
dc.subjectA-549 cell lineen_US
dc.subjectArticleen_US
dc.subjectCAG repeaten_US
dc.subjectcell inclusionen_US
dc.subjectcomparative studyen_US
dc.subjectcontrolled studyen_US
dc.subjectdegenerative diseaseen_US
dc.subjectdrug degradationen_US
dc.subjectdrug mechanismen_US
dc.subjecthumanen_US
dc.subjecthuman cellen_US
dc.subjectimmunocytochemistryen_US
dc.subjectimmunofluorescenceen_US
dc.subjectimmunofluorescence microscopyen_US
dc.subjectpriority journalen_US
dc.subjectprotein aggregationen_US
dc.subjectprotein qualityen_US
dc.subjecttransient transfectionen_US
dc.subjectubiquitinationen_US
dc.subjectupregulationen_US
dc.subjectbiological modelen_US
dc.subjectchemistryen_US
dc.subjectdrug effecten_US
dc.subjectenzyme stabilityen_US
dc.subjectmetabolismen_US
dc.subjectnerve degenerationen_US
dc.subjectpathologyen_US
dc.subjectphysiological stressen_US
dc.subjectprotein degradationen_US
dc.subjectprotein foldingen_US
dc.subjectsolubilityen_US
dc.subjectA549 Cellsen_US
dc.subjectalpha-Synucleinen_US
dc.subjectEnzyme Stabilityen_US
dc.subjectFlavonoidsen_US
dc.subjectHumansen_US
dc.subjectInclusion Bodiesen_US
dc.subjectLuciferasesen_US
dc.subjectModels, Biologicalen_US
dc.subjectMutant Proteinsen_US
dc.subjectNerve Degenerationen_US
dc.subjectPeptidesen_US
dc.subjectPolyphenolsen_US
dc.subjectProteasome Endopeptidase Complexen_US
dc.subjectProtein Aggregatesen_US
dc.subjectProtein Foldingen_US
dc.subjectProteolysisen_US
dc.subjectSolubilityen_US
dc.subjectStress, Physiologicalen_US
dc.subjectSuperoxide Dismutaseen_US
dc.subjectUbiquitin-Protein Ligasesen_US
dc.subjectUp-Regulationen_US
dc.titlePolyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregationen_US
dc.typeJournal Articleen_US
Appears in Collections:Department of Biosciences and Biomedical Engineering

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: